Skip to main content
Signal8

Helix BioPharma Corp. (HBPCF)

Helix BioPharma Corp. is a Canadian enterprise focused on immuno-oncology. The company's research and development efforts include L-DOS47, a drug candidate aimed at treating non-small cell lung cancer, and V-DOS47, which is designed to interact with vascular epithelial growth factor receptor 2 (VEGFR2). Helix has established collaborative agreements to further its research. One such partnership with Moffitt Cancer Center involves studying L-DOS47's pharmacodynamics and exploring the advantages of co-administering it with immune checkpoint inhibitors. A separate collaboration with University Hospital Tuebingen focuses on evaluating L-DOS47's therapeutic impact on CEACAM6-positive cancer models, employing advanced preclinical metabolic imaging techniques. The company's corporate headquarters are located in Toronto, Canada.

Sector: Biotechnology

Industry: Biotechnology

Helix BioPharma Corp. logo

Helix BioPharma Corp.

OTC:HBPCFHealthcare
CLOSED
Mkt Cap-
EV-
Float46.72M
O/S169.62M
VOL200 sh
$ Vol$248
Inst Own-
Net Cash/Sh-
EarningsDec 10 · in 3w
Dilution
Short interest (FINRA)
Not computed yet: no FINRA short interest has been matched to this float.

Float 46.72M · FMP free float

5
Mar 31 (231d)prev 5– 0.0%
1.00
Mar 31 (231d)prev 999.99▼ 99.9%
Borrow (IBKR)

The cost to borrow HBPCF shares for a short sale and how many IBKR has available, from IBKR's lendable-stock file, refreshed through the session.

IBKR borrow fee and availability is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually
Off-exchange & settlement
No fails on record for 16–31 Oct 2026.
Price, short interest & fails to deliver
Short interest · today's share basis9 settlements
Latest short interest settlements (today's share basis)
DateShares short
Mar 31, 20265 sh
Mar 13, 20265 sh
Feb 27, 20265 sh
Feb 13, 20265 sh
Jan 30, 20265 sh

A stock split executed inside this window; every settlement plotted has been carried onto today’s share basis, so the line does not step at the split.

The three panels share one date axis, so a point's position is its date; each has its own value axis. Short interest is plotted on today's share basis, so the line does not step where a split does.

Off-exchange short volume

Too few published sessions to show a reading in context.

ATS venues (dark pools)

FINRA's weekly alternative trading system (dark pool) volume for HBPCF: the share of off-exchange volume that traded on an ATS, and each venue by shares and trades.

The ATS venue breakdown is included in Signal8 ProUpgrade to Pro · $40.67/mo billed annually